Skip to content
healthcare.dev

MiraLAX

NDC 76420-489, Polyethylene Glycol 3350, powder, for solution, from ASCLEMED USA INC..

Product NDC
76420-489
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA022015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-489 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
76420-489-107642004891010 PACKET in 1 CARTON (76420-489-10) / 17 g in 1 PACKET
76420-489-207642004892020 POUCH in 1 CARTON (76420-489-20) / 17 g in 1 POUCH
76420-489-247642004892424 PACKET in 1 CARTON (76420-489-24) / 17 g in 1 PACKET
76420-489-7776420048977765 g in 1 BOTTLE, PLASTIC (76420-489-77)
76420-489-8576420048985850 g in 1 BOTTLE, PLASTIC (76420-489-85)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 76420-489 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-489 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-489. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.